DENTSPLY International (XRAY) : Gavekal Capital scooped up 33,461 additional shares in DENTSPLY International during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 12, 2016. The investment management firm now holds a total of 261,290 shares of DENTSPLY International which is valued at $15,700,916.DENTSPLY International makes up approximately 5.69% of Gavekal Capital’s portfolio.
DENTSPLY International opened for trading at $60 and hit $60.11 on the upside on Friday, eventually ending the session at $60.09, with a gain of 0.10% or 0.06 points. The heightened volatility saw the trading volume jump to 7,14,762 shares. Company has a market cap of $8,420 M.
Other Hedge Funds, Including , Capstone Asset Management Co reduced its stake in XRAY by selling 19,263 shares or 43.04% in the most recent quarter. The Hedge Fund company now holds 25,493 shares of XRAY which is valued at $1,531,874. DENTSPLY International makes up approx 0.04% of Capstone Asset Management Co’s portfolio.Dnb Asset Management As boosted its stake in XRAY in the latest quarter, The investment management firm added 49,200 additional shares and now holds a total of 133,404 shares of DENTSPLY International which is valued at $8,016,246. DENTSPLY International makes up approx 0.17% of Dnb Asset Management As’s portfolio.Eagle Asset Management Inc reduced its stake in XRAY by selling 184,491 shares or 39.2% in the most recent quarter. The Hedge Fund company now holds 286,108 shares of XRAY which is valued at $17,023,426. DENTSPLY International makes up approx 0.12% of Eagle Asset Management Inc’s portfolio.Chevy Chase Trust Holdings boosted its stake in XRAY in the latest quarter, The investment management firm added 90,667 additional shares and now holds a total of 212,862 shares of DENTSPLY International which is valued at $12,665,289. DENTSPLY International makes up approx 0.07% of Chevy Chase Trust Holdings’s portfolio.
On the company’s financial health, DENTSPLY International reported $0.65 EPS for the quarter, based on the information available during the earnings call on Feb 12, 2016. Analyst had a consensus estimate of $0.65. The company had revenue of $671.10 million for the quarter, compared to analysts expectations of $687.35 million. The company’s revenue was down -6.7 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.60 EPS.
Many Wall Street Analysts have commented on DENTSPLY International. DENTSPLY International was Downgraded by Morgan Stanley to ” Equal-Weight” on Mar 24, 2016. DENTSPLY International was Initiated by Credit Suisse to “Outperform” on Mar 16, 2016. Jefferies Resumed DENTSPLY International on Mar 3, 2016 to “Buy”, Price Target of the shares are set at $70.
DENTSPLY International Inc. is a designer developer manufacturer and marketer of a range of consumable dental products for the professional dental market. It operates through three segments: Dental Consumable and Certain International Businesses; Dental Specialty and Laboratory and Certain Global Distribution Businesses and Healthcare and Emerging Markets Businesses. All the segments are primarily engaged in the design manufacture and distribution of dental and medical products in four product categories. Its Dental Consumable Products consist of dental supplies and devices and small equipment used in dental offices. Its Dental Laboratory Products are used in the preparation of dental appliances by dental laboratories. Its Dental Specialty Products are specialized treatment products used within the dental office and laboratory settings. Its Consumable Medical Device Products consist mainly of urology catheters certain surgical products medical drills and other products.